Sobre nosotros
Cantor Fitzgerald is a leading global financial services firm, serving clients from over 30 offices around the world. Founded in 1945 as a securities brokerage and investment bank, the firm pioneered computer-based bond trading, built one of the broadest distribution networks in the industry and became the market’s premier dealer of government securities. Today, Cantor Fitzgerald is known for its strength across a diverse array of businesses, including equity and fixed income capital markets, investment banking, commercial real estate finance and services, prime brokerage, asset management and wealth management, and e-commerce and online ventures. In all its businesses, the firm is an acknowledged leader in developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. This commitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. For more information please visit www.cantor.com.
- Sitio web
-
http://www.cantor.com
Enlace externo para Cantor Fitzgerald
- Sector
- Servicios financieros
- Tamaño de la empresa
- Más de 10.001 empleados
- Sede
- New York, New York
- Tipo
- De financiación privada
- Especialidades
- Debt Capital Markets, Equity Capital Markets, Investment Banking Service, Commercial Real Estate Financing, Prime Brokerage, E-commerce, Gaming Technology, Investment Management, SPACs, ATMs y Research
Ubicaciones
Empleados en Cantor Fitzgerald
Actualizaciones
-
#Nvidia has transformed from a data center business valued at less than $10 billion just over two years ago to briefly becoming the world's most valuable company, surpassing Apple and Microsoft. Cantor's CJ Muse explores Nvidia's leadership in #AI and the significant impact AI is having on driving semiconductor demand.
-
During our recent Biotech Panel moderated by Eric Schmidt, four specialist fund managers shared their insights on exciting themes in the biotech sector. Here are some key takeaways: To learn more about Cantor’s insights on biotech or future events hosted by Cantor’s Prime and Capital Introduction team, please reach out to us: https://lnkd.in/eB6TnVmE.
-
Cantor Prime Services is capturing the attention of smaller hedge funds often overlooked by major banks. Our enhanced European offering has plans to expand its capabilities, providing tailored, cost-effective solutions for smaller funds. Read what Sean Capstick, Chief Executive Officer and Head of Prime Brokerage at Cantor Fitzgerald Europe, had to say in Hedgeweek. Interested in learning more about Cantor Prime Services? Reach out to us here: https://lnkd.in/eB6TnVmE
-
Last week, Cantor's Capital Introduction team hosted its inaugural Biotech Panel, moderated by Senior Managing Director and Senior Biotechnology Analyst, Eric Schmidt, Ph.D. Panelists shared their insights on the latest trends and future directions in biotechnology, discussing groundbreaking therapies, diagnostics, and innovative solutions driving the sector forward. A special thank you to our panelists for their invaluable contributions to the success of this event: Anna Cosslett Yaeger, Partner & Head of Public Equities of 5AM Ventures; Vincent Aita, CIO & Managing Partner of Cutter Capital Management, LP; Kevin Pyun, CIO of Dellora Investments; and Rod Wong, CIO & Managing Partner of RTW Investments, LP. If you missed the panel or are interested in learning more about Cantor Prime Services and our Capital Introduction capabilities, please reach out to us here: https://lnkd.in/eB6TnVmE.
-
-
The semiconductor industry is primed for an elongated cycle, with the next peak likely in 2026. Cantor's CJ Muse, Senior Managing Director, Semiconductors and Semiconductor Equipment, explores the key trends and technologies fueling semiconductor demand. #CantorCalls #AI #MarketResearch #Semiconductors
-
Biopharma's hot topic - weight loss drugs – will take center stage when Cantor’s Louise Chen speaks at the Seeking Alpha Investing Summit on June 18, 2024. Register below to attend and learn about how the GLP-1 drug market is anticipated to become the best-selling drug class in 2024. https://ow.ly/YW4P50SiQ4u
-
-
Companies that develop treatments for rare diseases are able to drive real value, despite a prior view that they were low market opportunities. Our research analyst, Kristen Kluska, unpacks how our research team uncovers the true impact of these companies. #CantorCalls #MarketResearch #RareDiseases
-
The eVTOL industry is poised to continue its path towards commercialization, as the US government reauthorizes the FAA and allocates funding. Learn what expert, Andres Sheppard, is taking away from the development. #eVTOLS #TechInvesting #MarketResearch #Innovation #Sustainability #Mobility